TLR4 and prostate carcinoma: In contrast with our previous study, Zhang et al. in a study on prostate cancer cells showed that ligation of TLR-4 with lipopolysaccharide (LPS) abrogated docetaxel-induced growth suppression in PC-3 prostate cancer cells (42).